Atlas Trials

Inhalation of Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for Autoimmune Pulmonary Alveolar Proteinosis (PAP)

Clinical trial NCT02243228 · UNKNOWN

Trial details

NCT number
NCT02243228
Sponsor
Peking Union Medical College Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Autoimmune Pulmonary Alveolar Proteinosis
Start date
2014-08-01
Primary completion
2017-08-01
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.